Heteronuclear dual-metal atom catalysts for nanocatalytic tumor therapy
文献类型：期刊论文
| 作者 | J. Y. Han and J. Q. Guan |
| 刊名 | Chinese Journal of Catalysis
 |
| 出版日期 | 2023 |
| 卷号 | 47页码:1-31 |
| ISSN号 | 0253-9837 |
| DOI | 10.1016/s1872-2067(22)64207-4 |
| 英文摘要 | Due to excellent catalytic activity and high atomic utilization rate, single atom catalysts (SACs) have become a rising star in the field of nanocatalytic medicine. Heteronuclear dual-atom catalysts (HDACs) retain the advantages of monoatomic catalysts, have more optionally regulated coordina-tion environment, possess favorable synergistic effects between different active sites, and can break through the restriction of adsorption ratio of SACs, making them the most ideal candidates for cata-lytic tumor therapy. In this review, we first introduce the advanced characterization methods of HDACs. Then, HDACs in different application fields are classified and elaborated according to vari-ous preparation strategies. According to the pharmacodynamic mechanisms, the application of HDACs in the field of nanocatalytic tumor therapy is emphatically introduced. Finally, a concise but focused summary and perspective is provided to outline the current challenges and prospects for future development of HDACs for oncology therapy. (c) 2023, Dalian Institute of Chemical Physics, Chinese Academy of Sciences. Published by Elsevier B.V. All rights reserved. |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 源URL | [http://ir.ciomp.ac.cn/handle/181722/67508]  |
| 专题 | 中国科学院长春光学精密机械与物理研究所 |
| 推荐引用方式 GB/T 7714 | J. Y. Han and J. Q. Guan. Heteronuclear dual-metal atom catalysts for nanocatalytic tumor therapy[J]. Chinese Journal of Catalysis,2023,47:1-31. |
| APA | J. Y. Han and J. Q. Guan.(2023).Heteronuclear dual-metal atom catalysts for nanocatalytic tumor therapy.Chinese Journal of Catalysis,47,1-31. |
| MLA | J. Y. Han and J. Q. Guan."Heteronuclear dual-metal atom catalysts for nanocatalytic tumor therapy".Chinese Journal of Catalysis 47(2023):1-31. |
入库方式： OAI收割
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。